BOVA v. ABBOTT LABORATORIES, INC.

CourtDistrict Court, M.D. North Carolina
DecidedSeptember 28, 2023
Docket1:21-cv-00274
StatusUnknown

This text of BOVA v. ABBOTT LABORATORIES, INC. (BOVA v. ABBOTT LABORATORIES, INC.) is published on Counsel Stack Legal Research, covering District Court, M.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BOVA v. ABBOTT LABORATORIES, INC., (M.D.N.C. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF NORTH CAROLINA

DAVID J. BOVA, ) ) Plaintiff, ) ) v. ) 1:21-CV-274 ) ABBOTT LABORATORIES, INC.; ) ABBVIE INC.; KOS ) PHARMACEUTICALS, INC.; and ) JOHN DOE, PLAN ADMINISTRATOR; ) ) Defendants. )

MEMORANDUM OPINION AND ORDER OSTEEN, JR., District Judge Before this court are a Motion to Dismiss Plaintiff’s Second Amended Complaint, (Doc. 55), filed by Defendants AbbVie Inc. (“AbbVie”) and Kos Pharmaceuticals, Inc. (“Kos”), and a Motion to Dismiss Second Amended Complaint, (Doc. 57), filed by Defendants Abbott Laboratories, Inc. (“Abbott”) and John Doe, Plan Administrator (“Doe”). For the following reasons, this court will grant AbbVie and Kos’s motion, (Doc. 55), in part, and grant Abbott and Doe’s motion, (Doc. 57), in part. Plaintiff’s remaining claims will be dismissed without prejudice for lack of subject matter jurisdiction. I. FACTUAL BACKGROUND On a motion to dismiss, a court must “accept as true all of the factual allegations contained in the complaint.” Ray v. Roane, 948 F.3d 222, 226 (4th Cir. 2020) (internal quotation mark omitted) (quoting King v. Rubenstein, 825 F.3d 206, 212 (4th Cir. 2016)). The facts, taken in the light most favorable to Plaintiff, are as follows. Plaintiff David J. Bova began working at Kos in 1992. (Sec. Am. Compl. (Doc. 51) ¶ 13; Ex. A (“Employment Agreement”)

(Doc. 51-1) at 2.)1, 2 In 2001, Kos sent Plaintiff a letter “confirm[ing] the understandings that [they] ha[d] reached concerning [Plaintiff’s] ongoing involvement with the Company.” (Ex. B (“Letter Agreement”) (Doc. 51-2) at 2; Sec. Am. Compl. (Doc. 51) ¶ 14.) Among other things, the Letter Agreement stated

1 All citations in this Memorandum Opinion and Order to documents filed with the court refer to the page numbers located at the bottom right-hand corner of the documents as they appear on CM/ECF. 2 Because the Second Amended Complaint “incorporate[s] [the exhibits] into the complaint by reference,” Oberg v. Pa. Higher Educ. Assistance Agency, 745 F.3d 131, 136 (4th Cir. 2014), and because Defendants rely on these exhibits in their briefs, (see, e.g., Mem. of Law by Defs. Kos and AbbVie in Supp. of Their Rule 12(b)(6) Mot. to Dismiss Pl.’s Sec. Am. Compl. (“Kos and AbbVie’s Br.”) (Doc. 56) at 2; Mem. of Law in Supp. of Abbott Laboratories, Inc. and John Doe’s Mot. to Dismiss Sec. Am. Compl. (“Abbott and Doe’s Br.”) (Doc. 58) at 3), this court finds the exhibits may properly be considered without converting the motion to dismiss to one for summary judgment, see Goldfarb v. Mayor & City Council of Balt., 791 F.3d 500, 508 (4th Cir. 2015). that “[i]f and when an employee pension plan is implemented for the Company, you will be considered eligible based on your tenure with the Company through your last day of active employment (presumably, July 31, 2002) and your age, subject to the provisions of such a plan.” (Letter Agreement (Doc. 51-2) at 2; Sec. Am. Compl. (Doc. 51) ¶ 15.) Plaintiff’s last day of employment with Kos was July 31, 2002. (Sec. Am. Compl. (Doc. 51) ¶ 16.) In 2006, Kos was acquired by Abbott pursuant to an

Agreement and Plan of Merger. (Ex. H (“Merger Agreement”) (Doc. 51-8); Sec. Am. Compl. (Doc. 51) ¶ 17.) The Merger Agreement was dated as of November 5, 2006, (Merger Agreement (Doc. 51-8) at 1), and the “Effective Time” was defined as “the date and time of the acceptance of the filing of the Articles of Merger by the Florida Department of State, Division of Corporations, or such later time as is specified in the Articles of Merger,” (id. at 12 (§ 1.5)). “Parent” is defined as “Abbott Laboratories, an Illinois corporation,” “Company” is defined as “Kos Pharmaceuticals, Inc., a Florida corporation,” and “Surviving Corporation” is defined as the company resulting from the merger of an Abbott wholly owned subsidiary into Kos. (Id.

at 7, 11 (§ 1.4).) As to employee benefits matters, the Merger Agreement provides that: [a]s of and after the Effective Time, Parent will, or will cause the Surviving Corporation to, give Company Employees who are employed by Parent or its Subsidiaries immediately following the Effective Time full credit for purposes of eligibility and vesting and benefit accruals . . . under any employee benefit (including vacation) plans, programs, policies and arrangements maintained for the benefit of Company Employees as of and after the Effective Time by Parent, its Subsidiaries or the Surviving Corporation for the Company Employees’ pre-Effective Time service with the Company, its Subsidiaries and their predecessor entities, . . . to the same extent recognized by the Company immediately prior to the Effective Time.

(Id. at 42 (§ 6.5(b)) (emphasis added).) “Company Employees” is defined as “any current, former or retired employee, officer, consultant, independent contract or director of the Company or its Subsidiaries.” (Id. at 25 (§ 3.10(a).)3 At the time of the merger, Abbott operated a pension plan within the meaning of 29 U.S.C. § 1002(2)(A). (Ex. E (“2007 Abbott Pension Plan”) (Doc. 51-5); Ex. G (“2021 Abbott Pension Plan”) (Doc. 51-7); together, the “Abbott Pension Plan.”) Plaintiff alleges that Abbott’s plan “became Kos’ plan” when the merger occurred. (Sec. Am. Compl. (Doc. 51) ¶ 30.) However, Plaintiff does not allege that he was employed by Abbott immediately following the Effective Time, on or after November 5, 2006, (id. ¶ 16 (“Plaintiff’s last day of employment with Kos

3 There is no allegation that Kos was a subsidiary of Abbott at the time of the merger. was July 31, 2002”); id. ¶ 24 (“Plaintiff worked for Kos from December 18, 1992, . . . until to July 31, 2002”). The Merger Agreement does not provide a definition for what it means to be “employed by Parent . . . immediately following the Effective Time,” (see Merger Agreement (Doc. 51-8) at 42), however, the Abbott Pension Plan provides a definition for “employee.” The Abbott Pension Plan states that an individual is an “employee” “only if . . . an employer treats that individual as its

employee for purposes of employment taxes and wage withholding for Federal income taxes.” (2007 Abbott Pension Plan (Doc. 51-5) at 9–10 (§ 2.1); 2021 Abbott Pension Plan (Doc. 51-7) at 10–11 (§ 2.1).) To be eligible to participate in the Abbott Pension Plan in any given year, an individual must have been an employee during that same year. (Id.) Plaintiff does not allege that he met the Abbott Pension Plan’s definition of “employee” in any year for which he seeks benefits, and does not allege facts which support a finding or inference that he meets any of the eligibility criteria for the Abbott Pension Plan.4 Instead,

4 Plaintiff does, however, supply the court with protracted references to the “Retirement Dates,” “Amount of Retirement Income,” and “Payment of Benefits” sections of the Abbott Pension Plan. (Sec. Am. Compl. (Doc. 51) ¶¶ 21-23, 25-26.) It is unclear to the court why Plaintiff so explicitly pleads the calculus of his alleged benefit award, yet omits any reference to the Abbott Pension Plan’s eligibility provisions. Plaintiff argues that his agreement with Kos supports his claim for benefits from the Abbott Pension Plan. (See, e.g., Pl.’s Resp. to Mot. to Dismiss by Defs. Kos & AbbVie (Doc. 59) at 9.) Abbott also administered a health and welfare benefits plan within the meaning of 29 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Firestone Tire & Rubber Co. v. Bruch
489 U.S. 101 (Supreme Court, 1989)
Curtiss-Wright Corp. v. Schoonejongen
514 U.S. 73 (Supreme Court, 1995)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Philips v. Pitt County Memorial Hospital
572 F.3d 176 (Fourth Circuit, 2009)
McRae v. Rogosin Converters, Inc.
301 F. Supp. 2d 471 (M.D. North Carolina, 2004)
Estate of Williams-Moore v. Alliance One Receivables Management, Inc.
335 F. Supp. 2d 636 (M.D. North Carolina, 2004)
Brooks v. Metrica, Inc.
1 F. Supp. 2d 559 (E.D. Virginia, 1998)
Occupy Columbia v. Nikki Haley
738 F.3d 107 (Fourth Circuit, 2013)
Gordon Goines v. Valley Community Services Board
822 F.3d 159 (Fourth Circuit, 2016)
Adrian King, Jr. v. Jim Rubenstein
825 F.3d 206 (Fourth Circuit, 2016)
Tina Ray v. Michael Roane
948 F.3d 222 (Fourth Circuit, 2020)
Bobby P. Kearney, MD, PLLC v. Blue Cross & Blue Shield Northcarolina
376 F. Supp. 3d 618 (M.D. North Carolina, 2019)
Coleman v. Roofing Concepts, Inc.
969 F.2d 54 (Fourth Circuit, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
BOVA v. ABBOTT LABORATORIES, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/bova-v-abbott-laboratories-inc-ncmd-2023.